lysine has been researched along with Lymphoma, Large B-Cell, Diffuse in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, Y; Fan, Y; Gu, D; Gu, H; Lin, T; Mao, R; Shen, H; Wang, Z; Wu, Y; Xian, H | 1 |
| Assouline, SE; Cerchietti, L; Krumsiek, J; Mann, KK; Marullo, R; Patel, J; Pera, B; Phillip, JM; Román, L | 1 |
| Xiong, J; Zhao, WL | 1 |
| Cheong, JW; Choi, SE; Oh, EJ; Yang, WI; Yoon, SO | 1 |
| Andersson, PO; Hasselblom, S; Karlsson, BG; Nilsson-Ehle, H; Pedersen, A; Pinto, R; Stenson, M | 1 |
| Atadja, P; Dillon, MP; Fang, D; Feng, L; Fu, X; Gabriel, T; Gao, Z; Gu, J; Guo, H; Huang, Y; Jiang, X; Li, L; Lingel, A; Liu, X; Liu, Y; Mi, Y; Oyang, C; Qi, W; Shultz, MD; Sun, Y; Wang, L; Wang, Y; Yu, Z; Zeng, J; Zhang, C; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, Q; Zhao, K; Zhao, M | 1 |
| Licht, JD; Martinez-Garcia, E | 1 |
| Ansorge, S; Bank, U; Bühling, F; Faust, J; Kähne, T; Kunt, D; Neubert, K; Reinhold, D | 1 |
8 other study(ies) available for lysine and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
USP7 sustains an active epigenetic program via stabilizing MLL2 and WDR5 in diffuse large B-cell lymphoma.
Topics: Cell Line, Tumor; DNA-Binding Proteins; Epigenesis, Genetic; Humans; Intracellular Signaling Peptides and Proteins; Lymphoma, Large B-Cell, Diffuse; Lysine; Neoplasm Proteins; Ubiquitin-Specific Peptidase 7 | 2022 |
Metabolomic Profiling Reveals Cellular Reprogramming of B-Cell Lymphoma by a Lysine Deacetylase Inhibitor through the Choline Pathway.
Topics: Animals; Cell Line, Tumor; Cellular Reprogramming; Choline; Choline Kinase; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Lymphoma, Large B-Cell, Diffuse; Lysine; Male; Metabolome; Metabolomics; Mice; Morpholines; Panobinostat; Pyrimidines; Signal Transduction; Xenograft Model Antitumor Assays | 2018 |
Targetable Metabolic Vulnerability in Diffuse Large B-Cell Lymphoma.
Topics: Cellular Reprogramming; Choline; Humans; Lymphoma, Large B-Cell, Diffuse; Lysine; Metabolomics | 2018 |
Diffuse large B-cell lymphoma with histone H3 trimethylation at lysine 27: another poor prognostic phenotype independent of c-Myc/Bcl2 coexpression.
Topics: Aged; DNA Methylation; Enhancer of Zeste Homolog 2 Protein; Female; Histones; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lysine; Male; Middle Aged; Phenotype; Polycomb Repressive Complex 2; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Tissue Array Analysis | 2014 |
Serum nuclear magnetic resonance-based metabolomics and outcome in diffuse large B-cell lymphoma patients - a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Aspartic Acid; Biomarkers, Tumor; Cadaverine; Disease-Free Survival; Female; Humans; Hydroxybutyrates; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Lysine; Magnetic Resonance Spectroscopy; Male; Metabolomics; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Ornithine; Pilot Projects; Prognosis; Pyrrolidonecarboxylic Acid; Treatment Outcome; Valine; Young Adult | 2016 |
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Crystallography, X-Ray; Dogs; Female; Haplorhini; Histones; Humans; Lymphoma, Large B-Cell, Diffuse; Lysine; Male; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Docking Simulation; Polycomb Repressive Complex 2; Rats; Sulfones; Triazoles | 2017 |
Deregulation of H3K27 methylation in cancer.
Topics: DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Germinal Center; Histones; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lysine; Methylation; Mutation; Polycomb Repressive Complex 2; Transcription Factors | 2010 |
Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells.
Topics: Blotting, Western; Cell Division; Cytokines; Dipeptidyl Peptidase 4; DNA; DNA Replication; Humans; Isoelectric Focusing; Lymphoma, Large B-Cell, Diffuse; Lysine; Piperidines; Thiazoles; Tumor Cells, Cultured | 1994 |